Yuk-Fai Lam
Overview
Explore the profile of Yuk-Fai Lam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
342
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko K, Lam Y, Cheung K, Hung I, Leung W
Aliment Pharmacol Ther
. 2022 May;
56(2):301-309.
PMID: 35546255
Background: Efficacy with conventional intra muscular (IM) hepatitis B vaccination in patients with inflammatory bowel disease (IBD) is suboptimal. Aim: To compare the immunogenicity of intradermal (ID) hepatitis B vaccination...
2.
Seto W, Liu K, Mak L, Cloherty G, Wong D, Gersch J, et al.
Gut
. 2020 Aug;
70(4):775-783.
PMID: 32759300
Background: Treatment cessation in chronic HBV infection may be durable in certain patient subgroups before hepatitis B surface antigen (HBsAg) seroclearance. The role of serum HBV RNA in determining treatment...
3.
Liu K, Seto W, Lau E, Wong D, Lam Y, Cheung K, et al.
J Infect Dis
. 2019 Jan;
219(12):1924-1933.
PMID: 30668746
Background: Viral hepatitis epidemiological data are important for the World Health Organization plan of eliminating viral hepatitis. We aimed to document the prevalence of viral hepatitis A to E in...
4.
Lam Y, Seto W, Wong D, Cheung K, Fung J, Mak L, et al.
Clin Transl Gastroenterol
. 2017 Oct;
8(10):e125.
PMID: 29072673
Objectives: We aimed to determine the levels of alanine aminotransferase (ALT), hepatitis B virus DNA (HBV DNA), HBsAg, and a novel viral marker (hepatitis B core-related antigen (HBcrAg)); hepatitis B...
5.
Seto W, Chan T, Hwang Y, Wong D, Fung J, Liu K, et al.
Hepatology
. 2016 Dec;
65(5):1451-1461.
PMID: 28027590
Conclusion: HBsAg-negative, anti-HBc-positive patients had a high rate of HBV reactivation after allogeneic HSCT, with determinants of HBV reactivation including age ≥50 years and chronic graft-versus-host disease; treatment strategies based...
6.
Seto W, Wong D, Chan T, Hwang Y, Fung J, Liu K, et al.
Am J Gastroenterol
. 2016 Dec;
111(12):1858.
PMID: 27924098
No abstract available.
7.
Seto W, Wong D, Chan T, Hwang Y, Fung J, Liu K, et al.
Am J Gastroenterol
. 2016 Sep;
111(12):1788-1795.
PMID: 27644733
Objectives: Hepatitis B core-related antigen (HBcrAg) is a novel serum marker that correlates with intrahepatic hepatitis B virus (HBV) activity. Its association with HBV reactivation in hepatitis B surface antigen...
8.
Seto W, Chan T, Hwang Y, Wong D, Fung J, Liu K, et al.
J Clin Oncol
. 2014 Oct;
32(33):3736-43.
PMID: 25287829
Purpose: Patterns of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen (HBsAg) -negative, antihepatitis B core antigen antibody (anti-HBc) -positive patients with lymphoma receiving rituximab-containing chemotherapy have not...
9.
Seto W, Lam Y, Fung J, Wong D, Huang F, Hung I, et al.
J Gastroenterol Hepatol
. 2013 Dec;
29(5):1028-34.
PMID: 24325451
Background And Aim: Hepatitis B surface antigen (HBsAg) kinetics during long-term entecavir therapy has not been well investigated. Methods: We described the cumulative serologic, virologic, and biochemical outcomes and the...
10.
Lam Y, Wong D, Seto W, To K, Hung I, Fung J, et al.
J Gastroenterol Hepatol
. 2013 Aug;
29(3):533-9.
PMID: 23980639
Background And Aim: Studies show that polymorphisms in human leukocyte antigen (HLA)-DP loci and certain γ-interferon (IFN-γ) signaling pathway genes are related to persistence of hepatitis B virus (HBV) infection...